CA Stock MarketDetailed Quotes

ENBI Entheon Biomedical Corp

Watchlist
  • 0.155
  • 0.0000.00%
15min DelayMarket Closed Jun 21 14:58 ET
1.37MMarket Cap-3875P/E (TTM)

Entheon Biomedical Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
(Q3)Aug 31, 2022
(Q2)May 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-49.09%249.92K
-49.33%344.63K
-49.33%344.63K
53.72%381.81K
4.14%486.93K
-40.23%490.91K
-66.81%680.17K
-66.81%680.17K
-92.66%248.39K
-88.62%467.58K
-Cash and cash equivalents
-49.09%249.92K
-49.33%344.63K
-49.33%344.63K
53.72%381.81K
2.35%478.56K
-40.23%490.91K
-66.81%680.17K
-66.81%680.17K
-92.66%248.39K
-88.62%467.58K
-Other receivables
----
----
----
----
----
----
----
----
----
--300K
Total current assets
-55.60%286.9K
-46.78%396.08K
-46.78%396.08K
-28.29%420.87K
-50.46%549.32K
-62.70%646.21K
-76.80%744.22K
-76.80%744.22K
-85.16%586.9K
-77.80%1.11M
Non current assets
-Accumulated depreciation
----
----
----
----
----
----
----
----
---81.26K
---70.02K
Investment properties
----
----
----
----
----
----
----
----
18.26%529.64K
18.92%564.7K
-Including:Financial assets designated as fair value through profit or loss, Total
----
----
----
----
----
----
----
----
18.26%529.64K
18.92%564.7K
-Goodwill
----
----
----
----
----
----
----
----
-7.39%5.42M
20.71%5.57M
Regulatory assets
-92.23%6.45K
-85.23%6.23K
-85.23%6.23K
-75.69%10.87K
-76.30%7.08K
255.94%83K
49.10%42.19K
49.10%42.19K
5.86%44.72K
-62.15%29.86K
Liabilities
Current liabilities
-accounts payable
-66.16%51.01K
-44.83%85.33K
-44.83%85.33K
-33.77%41.57K
-89.38%89.04K
-84.44%150.73K
-83.33%154.65K
-83.33%154.65K
-84.06%62.76K
693.41%838.42K
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Other payable
-80.00%5K
-80.00%5K
-80.00%5K
--10K
--25K
--25K
--25K
--25K
----
----
Current liabilities
-66.16%51.01K
-44.83%85.33K
-44.83%85.33K
-33.77%41.57K
-92.18%89.04K
-84.44%150.73K
-83.33%154.65K
-83.33%154.65K
-84.06%62.76K
977.31%1.14M
Non current liabilities
Non current accrued expenses
----
----
----
----
----
----
----
----
4.12%148.95K
2,697.49%160.18K
Total non current liabilities
-66.16%51.01K
-44.83%85.33K
-44.83%85.33K
-33.77%41.57K
-92.18%89.04K
-84.44%150.73K
-83.33%154.65K
-83.33%154.65K
-84.06%62.76K
977.31%1.14M
Shareholders'equity
Share capital
3.14%19.96M
3.14%19.96M
3.14%19.96M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.13%19.35M
8.17%19.35M
-common stock
3.14%19.96M
3.14%19.96M
3.14%19.96M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.00%19.35M
0.13%19.35M
8.17%19.35M
Gains losses not affecting retained earnings
-9.91%1.66M
-42.09%1.66M
-42.09%1.66M
-52.46%1.66M
-53.70%1.66M
-45.89%1.85M
-11.42%2.87M
-11.42%2.87M
48.41%3.5M
75.39%3.6M
Total equity
-56.51%291.9K
-47.86%401.08K
-47.86%401.08K
-93.56%430.87K
-92.24%574.32K
-91.93%671.21K
-92.29%769.22K
-92.29%769.22K
-35.70%6.69M
-26.63%7.4M
(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022(Q3)Aug 31, 2022(Q2)May 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -49.09%249.92K-49.33%344.63K-49.33%344.63K53.72%381.81K4.14%486.93K-40.23%490.91K-66.81%680.17K-66.81%680.17K-92.66%248.39K-88.62%467.58K
-Cash and cash equivalents -49.09%249.92K-49.33%344.63K-49.33%344.63K53.72%381.81K2.35%478.56K-40.23%490.91K-66.81%680.17K-66.81%680.17K-92.66%248.39K-88.62%467.58K
-Other receivables --------------------------------------300K
Total current assets -55.60%286.9K-46.78%396.08K-46.78%396.08K-28.29%420.87K-50.46%549.32K-62.70%646.21K-76.80%744.22K-76.80%744.22K-85.16%586.9K-77.80%1.11M
Non current assets
-Accumulated depreciation -----------------------------------81.26K---70.02K
Investment properties --------------------------------18.26%529.64K18.92%564.7K
-Including:Financial assets designated as fair value through profit or loss, Total --------------------------------18.26%529.64K18.92%564.7K
-Goodwill ---------------------------------7.39%5.42M20.71%5.57M
Regulatory assets -92.23%6.45K-85.23%6.23K-85.23%6.23K-75.69%10.87K-76.30%7.08K255.94%83K49.10%42.19K49.10%42.19K5.86%44.72K-62.15%29.86K
Liabilities
Current liabilities
-accounts payable -66.16%51.01K-44.83%85.33K-44.83%85.33K-33.77%41.57K-89.38%89.04K-84.44%150.73K-83.33%154.65K-83.33%154.65K-84.06%62.76K693.41%838.42K
-Total tax payable --0--0--0--0--0--0--0--0--0--0
-Other payable -80.00%5K-80.00%5K-80.00%5K--10K--25K--25K--25K--25K--------
Current liabilities -66.16%51.01K-44.83%85.33K-44.83%85.33K-33.77%41.57K-92.18%89.04K-84.44%150.73K-83.33%154.65K-83.33%154.65K-84.06%62.76K977.31%1.14M
Non current liabilities
Non current accrued expenses --------------------------------4.12%148.95K2,697.49%160.18K
Total non current liabilities -66.16%51.01K-44.83%85.33K-44.83%85.33K-33.77%41.57K-92.18%89.04K-84.44%150.73K-83.33%154.65K-83.33%154.65K-84.06%62.76K977.31%1.14M
Shareholders'equity
Share capital 3.14%19.96M3.14%19.96M3.14%19.96M0.00%19.35M0.00%19.35M0.00%19.35M0.00%19.35M0.00%19.35M0.13%19.35M8.17%19.35M
-common stock 3.14%19.96M3.14%19.96M3.14%19.96M0.00%19.35M0.00%19.35M0.00%19.35M0.00%19.35M0.00%19.35M0.13%19.35M8.17%19.35M
Gains losses not affecting retained earnings -9.91%1.66M-42.09%1.66M-42.09%1.66M-52.46%1.66M-53.70%1.66M-45.89%1.85M-11.42%2.87M-11.42%2.87M48.41%3.5M75.39%3.6M
Total equity -56.51%291.9K-47.86%401.08K-47.86%401.08K-93.56%430.87K-92.24%574.32K-91.93%671.21K-92.29%769.22K-92.29%769.22K-35.70%6.69M-26.63%7.4M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg